-
Stay Connected
Get the latest news on exciting speakers, workshops & learning opportunities at ISDE 2021.
Subscribe for Updates
Esophageal cancer surgery places substantial demands on the body. Resection, reconstruction, inflammation, and the temporary effects of anesthesia can increase protein breakdown and make it difficult to maintain strength. Many patients also begin treatment with weight loss, swallowing problems, or reduced dietary intake.
Immunonutrition describes targeted nutritional support formulated with nutrients such as arginine, omega-3 fatty acids, and nucleotides. It is intended to support immune activity, modulate the inflammatory response, and help preserve tissue repair during the perioperative period. In esophageal surgery, it is usually considered alongside—not instead of—standard nutritional assessment and cancer treatment.
Evidence discussed through specialist education, including programs associated with the International Society for Diseases of the Esophagus, is most useful when applied to individual patients. The appropriate formula, timing, route, and duration depend on nutritional status, surgical plan, comorbidities, and local clinical protocols.
Dysphagia, pain, early satiety, and tumor-related inflammation can cause a rapid decline in energy and protein intake. Neoadjuvant chemotherapy or radiotherapy may intensify fatigue, nausea, taste changes, and weight loss. Low muscle mass can exist even when body weight appears acceptable, making a simple weight measurement insufficient.
Malnutrition is associated with weaker immunity, poorer wound healing, reduced mobility, and a higher risk of postoperative complications. Early screening should therefore include recent weight change, dietary intake, functional capacity, muscle status, and inflammatory or disease-related factors. A dietitian can then create a nutrition care plan before the operation rather than waiting for complications to develop.
Perioperative formulas may contain arginine, fish-oil-derived omega-3 fatty acids, glutamine, antioxidants, or nucleotides, although products vary considerably. Arginine is involved in immune-cell function and collagen formation. Omega-3 fatty acids may influence inflammatory signaling, while nucleotides support rapidly dividing cells involved in intestinal and immune function.
The proposed benefits include fewer infectious complications, improved immune response, and support for anastomotic or wound healing. Clinical results have not been uniform across all studies, and evidence specific to esophagectomy remains mixed. Immunonutrition should therefore be viewed as a structured component of multimodal perioperative care, not a guaranteed way to prevent complications.
Some protocols provide an oral or enteral immunonutrition formula for several days before surgery and continue it afterward. Preoperative use may be particularly relevant for patients with significant nutritional risk, while postoperative feeding supports recovery when oral intake is still limited. The surgical team must decide whether oral supplements, a feeding tube, or another enteral route is safest and practical.
Early enteral nutrition is often preferred when the gastrointestinal tract is functioning, but advancement must reflect the operation, aspiration risk, gastric emptying, and tolerance. High-output losses, severe ileus, or other complications can require a revised plan. Parenteral nutrition may be considered when enteral feeding is not possible or does not meet requirements.
| Approach | Main purpose | Potential advantages | Important considerations |
|---|---|---|---|
| Usual oral diet | Maintain everyday energy and protein intake | Familiar, flexible, and easy to personalize | Often inadequate with dysphagia, nausea, or early satiety |
| Standard oral or enteral formula | Increase calories and protein | Reliable nutrient delivery and broad availability | Does not specifically target immune or inflammatory pathways |
| Immunonutrition formula | Add selected immune-modulating nutrients | May support recovery in selected major cancer operations | Products differ; benefits in esophageal surgery are not consistent |
| Tube-based enteral feeding | Deliver nutrition when swallowing is restricted | Uses the functioning gut and can provide controlled intake | Requires monitoring for tolerance, aspiration, and tube-related problems |
| Parenteral nutrition | Provide nutrients intravenously | Useful when enteral feeding is contraindicated or insufficient | Invasive, costly, and associated with metabolic and infectious risks |
The choice should be based on nutrition screening, operative details, kidney and liver function, glycemic control, and the patient’s ability to eat safely. A formula should not be selected solely because it is marketed as immune-enhancing.
Nutrition is one element of an enhanced recovery pathway. Appropriate prehabilitation, smoking cessation, respiratory exercises, pain control, early mobilization, and careful fluid management may work together to improve functional recovery. Avoiding unnecessary fasting and restarting oral or enteral intake according to surgical guidance can also reduce the duration of nutritional deficits.
After esophagectomy, patients may experience reflux, dumping symptoms, delayed gastric emptying, or difficulty managing larger meals. Smaller, protein-rich meals and continued dietetic follow-up are often needed. Monitoring should include intake, hydration, bowel function, glucose, electrolytes, body weight, and functional progress rather than relying on a single laboratory marker.
Immunonutrition is not suitable in exactly the same way for every patient. Clinicians should review renal or hepatic impairment, metabolic instability, allergies, gastrointestinal function, fluid restrictions, and possible interactions with the wider treatment plan. Supplements should be sourced through the hospital or a qualified clinical team, particularly during chemotherapy and the surgical admission.
Patients benefit from clear explanations about the expected purpose and limitations of the intervention. Monitoring can show whether the patient is meeting protein and energy targets, tolerating the formula, and progressing toward oral intake. If adverse symptoms or poor tolerance occur, the route, dose, or product may need to change.
Specialist congress education helps clinicians compare emerging evidence and refine multidisciplinary care for esophageal disease. Explore the ISDE 2021 scientific resources, research presentations, and educational material to place immunonutrition within the wider evidence base for esophageal cancer surgery.